PALAZESTRANT

Clinical trials for PALAZESTRANT explained in plain language.

Never miss a new study

Get alerted when new PALAZESTRANT trials appear

Sign up with your email to follow new studies for PALAZESTRANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients to test new pill targeting advanced cancers

Disease control Recruiting now

This is the first study in people testing a new oral drug called OP-3136 for advanced or metastatic cancers, including certain types of breast, prostate, and lung cancer. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that i…

Matched conditions: PALAZESTRANT

Phase: PHASE1 • Sponsor: Olema Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PALAZESTRANT

Get alerted when new PALAZESTRANT trials appear

First patients to test new pill targeting advanced cancers